Similar stories

headline news | recent news | latest news | market news | recent topics | stock topics

Global news - chevrons indicate local prediction, arrows show global predictions, circles show importance

Text search

	Educational Podcasts You Listen To Inspired by the other thread about sharing more drug development content on this forum vs layoff posts, I realized one good way to do find similar content is podcasts. So what drug development/biotech/pharma/science podcasts do you all listen to, and why do you like them? I will start by recommending "Business of Biotech". The format is they interview a different C-suite person from a biotech each week and talk about their experience, career, current company/program, philosophy on drug development, etc. So different topics come up, for example, how a company was previously developing a certain asset and then decided to shelve it and pivot to a different asset-- what the thought process was and how they decided to go after a different target in the space. Not every episode is a homerun, but I've listened to a lot of good ones on it. What other ones do you all listen to? submitted by /u/Puzzleheaded_Soil275 [link] [comments] reddit - 12:07 Sat - story -
	Daiwa Securities Group Inc. Sells 124 Shares of Ascendis Pharma A/S (NASDAQ:ASND) Daiwa Securities Group Inc. lessened its stake in Ascendis Pharma A/S (NASDAQ:ASND – Free Report) by 4.5% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 2,630 shares of the biotechnology company’s stock after selling 124 shares during the period. Daiwa Securities Group Inc.’s holdings in Ascendis Pharma A/S were worth $331,000 at the […] americanbankingnews - 10:44 Sat - story - ASND US
	Daiwa Securities Group Inc. Buys 5,571 Shares of Legend Biotech Co. (NASDAQ:LEGN) Daiwa Securities Group Inc. lifted its holdings in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 2,134.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,832 shares of the company’s stock after acquiring an additional 5,571 shares during the quarter. Daiwa Securities […] americanbankingnews - 10:44 Sat - story -
	EMU Undergraduate Conference in Philosophy CFP Below is the advertisement for this Fall’s EMU Undergraduate Conference in Philosophy. If you have undergrads who are interested in presenting their work in Chinese philosophy at an undergraduate conference, we enthusiastically welcome such papers. The conference has been very successful in welcoming students from across the country, and even internationally. Prior conference programs can […] warpweftandway - 12:56 Sat - story -
	New patent for Purdue Pharma drug OXYCONTIN Annual Drug Patent Expirations for OXYCONTIN Oxycontin is a drug marketed by Purdue Pharma Lp and is included in one NDA. It is available from three suppliers. There are sixteen Source The post New patent for Purdue Pharma drug OXYCONTIN appeared first on Biotechblog . biotechblog - 04:15 Sat - story -
	IBRX - Institutional Money Potential and Good Plan Forward NOT FINANCIAL ADVICE Got the go ahead from mods to repost this. Hopefully all going to be good this time around. As always, my intent is to stay within the rules so if anything is off would appreciate direct feedback! Thanks :) Positive of reposting is that I am not as rushed as I was typing it up from work... haha TLDR: Looking at a number of mature pharma companies their institutional ownership usually is around 70% (give or take). IBRX is just at 8% so there is A LOT of room for institutional money to flow in as this solidifies itself as a legit pharma company. Their investor presentation from Friday has all the markings of a company that has it's shit together and is ready for the big leagues. My positions (total of about $1800 cost basis which is about 1/3rd of my current portfolio and above my usual $500 per play target). Note: It was rather small going into yesterday and then I double and tripled down as I wrapped my head around this thesis, so I ac reddit - 14:52 Sat - story -
	The dreaded question, to MS or not to MS. Hi All! Im currently deliberating whether or not I pull the trigger and decide to pursue a masters degree, would love to see what the opinions of some fellow biotechies are. I graduated a couple years ago with my Bachelors, Chemical Engineering. And have currently landed a fairly good job as Associate Scientist at a fairly large BioPharma company. As of now I have just about 3 years of Upstream/Downstream process development experience under my belt. And at this time is when im wondering if a masters degree would be beneficial to me. Ive done some research in programs and financial aid, and my company is only willing to put up 10k a year. Looking at ~2 ish year part time programs so 20k overall. I should also add I am fortunate enough to have no debt from my undergraduate. Finances are not too bad in the long run. But what is really holding me back is whether or not a masters degree would be worth it for career advancement. Ive heard some people say that in BioTech/Pharma it reddit - 01:43 Sat - story -
	How to get 5% p.a.^ dividend income as a passive investor (for the first 2 years based on the ETFs Issue Price during its initial offer period) (Lion-OCBC Securities APAC Financials Dividend Plus ETF review) Singapore investors love dividends. Whether you are a young investor growing your wealth, or a retiree looking for retirement income, its never too late to start investing for dividend yield. How to diversify your dividend income sources as a passive investor? Lets say youre a Singapore investor looking to invest for dividend yield today. […] thefinance sg - 00:50 Sat - story -
	The 76-year-old who has run every London Marathon Jeff Aston is one of six remaining runners who are given the title 'ever present'. bbci co uk - 06:17 Sat - story -
	Three Questions About Politics and the Campus Protests The encampments present a new wrinkle in a year already knotted by war abroad and domestic discord. nytimes - 15:08 Sat - story -
	Interview cancelled last minute Recruiter scheduled me an interview for a position at a pharma job. First time offered interview and was so excited. Got ready and they emailed me the day before that they are canceling the interview. No explanation. When I asked if we could reschedule they just ghosted me. Wtf! Beyond frustrated and unprofessional. submitted by /u/imironman2018 [link] [comments] reddit - 14:06 Sat - story -
	NRL Press Conference: Cowboys v Panthers - Round 8, 2024 - NRL.COM NRL Press Conference: Cowboys v Panthers - Round 8, 2024 NRL.COM Cowboys epic comeback thwarted as Penrith star shines in milestone game - What we learned Fox Sports Why Turuva was axed for Penriths win over Cowboys Sydney Morning Herald Final Cowboys team list: Round 8 v Panthers North Queensland Cowboys Ivan Cleary: We're trying to put the puzzle pieces together NRL.COM news google au - 10:45 Sat - story -
	St Kilda coach Ross Lyon leaves everyone confused after strange post-match press conference - 7NEWS St Kilda coach Ross Lyon leaves everyone confused after strange post-match press conference 7NEWS View Full coverage on Google News news google au - 05:11 Sat - story - COH US
	ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Barclays PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action - VXX NEW YORK, April 27, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds acquirers of a short position in Barclays' iPath Series B S&P 500 VIX Short-Term Futures Exchange Traded Note ('ETN') under the symbol 'VXXB' (hereinafter 'VXX') due to selling VXX... prnewswire:443 - 14:15 Sat - story -
	Nitto Denko Avecia Inc. accueille une nouvelle prsidente MILFORD, Massachusetts, 27 avril 2024 /PRNewswire/ -- Nitto Denko Avecia Inc. et Nitto Denko Avecia Pharma Services (Nitto Avecia), leader mondial dans le dveloppement et la fabrication d'oligonuclotides pour le march thrapeutique, ont annonc aujourd'hui que Tammy Cooper sera nomme... prnewswire:443 - 19:22 Sat - story -
	ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages HireRight Holdings Corporation Investors to Secure Counsel in Securities Class Action - HRT NEW YORK, April 27, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of HireRight Holdings Corporation (NYSE: HRT) pursuant and/or traceable to the registration statement and prospectus (collectively, the 'Offering Documents')... prnewswire:443 - 14:00 Sat - story -
	ROSEN, LEADING INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation BLUE NEW YORK, April 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of bluebird bio Inc. (NASDAQ: BLUE) resulting from allegations that bluebird may have issued materially misleading business information to the investing public. globenewswire - 13:47 Sat - story - BLUE US
	ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CKPT NEW YORK, April 27, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) between March 10, 2021 and December 15, 2023, both dates inclusive (the 'Class Period'), of the important June... prnewswire:443 - 20:30 Sat - story - CKPT US
	BLUE INVESTOR NEWS: TOP RANKED ROSEN LAW FIRM Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE NEW YORK, April 27, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of bluebird bio, Inc. (NASDAQ: BLUE) between April 24, 2023 and December 8, 2023, both dates inclusive (the 'Class Period'), of the important May 28, 2024... prnewswire:443 - 17:45 Sat - story - BLUE US
	Telecom Diary: Vodafone Idea: Start of a new era? Through the FPO, Vodafone Idea has put concerns of its survival and competitiveness away but it's not viable yet, as per a Ambit Capital report. A significant rise in mobile tariffs will be necessary following the fundraising to help Vodafone Idea in navigating the present crisis seamlessly. telecom economictimes indiatimes - 13:30 Sat - story -
	ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Plug Power Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PLUG NEW YORK, April 27, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Plug Power Inc. (NASDAQ: PLUG) between May 9, 2023 and January 16, 2024, both dates inclusive (the 'Class Period'), of the important May 21, 2024 lead... prnewswire:443 - 14:30 Sat - story -
	ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Perion Network Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action PERI NEW YORK, April 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Perion Network Ltd. (NASDAQ: PERI) between February 9, 2021 and April 5, 2024, both dates inclusive (the Class Period), of the important June 17, 2024 lead plaintiff deadline. globenewswire - 16:12 Sat - story - PERI US
	Finding bird flu in dairy cows means turbulent times ahead for livestock industry News that the U.S. government detected the bird flu virus in milk samples from sick cows in a number of states caught the attention of traders in dairy and livestock markets this week, and may eventually present a dilemma for consumers. marketwatch - 13:36 Sat - story -
	ROSEN, LEADING INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm OCGN NEW YORK, April 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ocugen, Inc. (NASDAQ: OCGN) between May 8, 2020 and April 1, 2024, both dates inclusive (the Class Period), of the important June 10, 2024 lead plaintiff deadline in the securities class action first filed by the Firm. globenewswire - 20:07 Sat - story -
	3 Top Warren Buffett Stocks to Buy in This Bull Market Imitating the master can make you a better investor. fool - 12:00 Sat - story -
	Pope Francis to advocate for ethical AI at G7 summit in Italy Pope Francis will attend the upcoming G7 conference in Italy, a session dedicated to artificial intelligence, where he will speak about the importance of ethics in the burgeoning world of AI, the Vatican says. upi - 16:55 Sat - story -
	Favorite Chemistry Quote I'm a recently retired high school chemistry teacher. My former student is graduating in May as the class valedictorian. She will be going to college to pursue a chemistry degree. I'm buying her the CRC Handbook of Chemistry and Physics as a graduation present. I want to write a meaningful, inspiring chemistry quote on the inside. I did a quick internet search and didn't find anything that I really liked. What is your favorite chemistry quote and who is attributed to? submitted by /u/Right-Independence33 [link] [comments] reddit - 12:42 Sat - story -
	Haliburton leads Pacers to win over Bucks Tyrese Haliburton converts a three-point play with 1.6 seconds left in overtime to give the Indiana Pacers a 2-1 lead over the Milwaukee Bucks in their Eastern Conference first-round play-off series. bbci co uk - 07:25 Sat - story - HAL US
	Is it normal to have mold spores on your hands? This is probably a strange question but I thought Id ask. I recently started a job as a microbiology technician. During one of my trainings, my supervisor was showing me how to collect fingertip samples using agar plates and he had me use my fingers. He ended up incubating the plates and one of them grew mold. Everyone on our team saw it and acted kinda disgusted about it and it honestly made me feel pretty shitty and self-conscious even though I know Im a very clean person. I know bacteria is present on everyones skin, but Ive never heard the same about mold. So is this normal or were they right to treat me like I had just taken a dive through a dumpster lol? submitted by /u/Character_Mail_3911 [link] [comments] reddit - 00:19 Sat - story -
	Meet the Press S76E49 Navigating the Political Crossroads Introduction In the area of American political journalism, few systems keep as much ancient and present-day significance as “Meet the Press.” Since its inception in 1947, the display has been a cornerstone of political discourse, offering a forum for policymakers, analysts, and pundits to interact in an enormous talk on urgent troubles handling the kingdom. […] The post Meet the Press S76E49 Navigating the Political Crossroads appeared first on TechBullion . techbullion - 18:35 Sat - story -